Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zhi-di Li"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Hepatocellular carcinoma (HCC) is an extremely heterogeneous malignant tumor with a high morbidity and mortality. Circular RNAs (circRNAs) are noncoding RNAs with high stability, organ/tissue/cell-specific expression and are conserved across species.
Externí odkaz:
https://doaj.org/article/a7bb6cfe2ef64c77bcc7306ecc66ba13
Autor:
Jing-Wen Zou, Zhi-Di Li, Hao-Sen Kang, Wen-Qin Zhao, Jing-Chuang Liu, You-Long Chen, Liang Ma, Hua-Yi Hou, Si-Jing Ding
Publikováno v:
ACS Omega, Vol 6, Iss 42, Pp 28347-28355 (2021)
Externí odkaz:
https://doaj.org/article/5420c12899c14f11a8cac3d20bd74e99
Autor:
Zhi-Di Li, Hao-Sen Kang, Ming-Yang Long, Jing-Chuan Liu, Tao Zhou, Dan Zhu, Liang Ma, Si-Jing Ding, Li Zhou
Publikováno v:
The Journal of Physical Chemistry C. 126:12129-12135
Glioma is one of the most primary malignant brain tumors, and glioblastoma multiform (GBM) is the most common and highly aggressive glioma. Most GBM are high malignant, poor prognosis, resistant to conventional therapy, and prone to recurrence. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9edd281ea6553842054aef7a897d763f
https://doi.org/10.21203/rs.3.rs-2473762/v1
https://doi.org/10.21203/rs.3.rs-2473762/v1
Autor:
Zi-Yi, Chen, Jie, Li, Shu-Di, Zhu, Zhi-Di, Li, Jia-Lin, Yu, Jie, Wu, Chong, Zhang, Ling-Hui, Zeng
Publikováno v:
Experimental and Therapeutic Medicine
The overall outcomes for patients with advanced liver cancer are far from satisfactory, and the development of more effective therapeutic strategies for liver cancer is required. Sulforhodamine blue and colony formation assays were performed to detec
Autor:
Chong Zhang, Lin-Wen Wu, Zhi-Di Li, Man-Man Zhang, Jie Wu, Fei-Hua Du, Ling-Hui Zeng, Yang-Ling Li
Publikováno v:
International journal of oncology. 60(4)
Hypoxia promotes drug resistance and induces the expression of hypoxia inducible factor (HIF)‑1α in liver cancer cells. However, to date, no selective HIF‑1α inhibitor has been clinically approved. The aim of this study is to investigate a drug